Erin Palmer had a devastating encounter with a psychopath as a child. Now a grad student and scientist, she’s devoting her life to studying these monsters. When her research catches the attention of Hugh Raborn, a brilliant neuroscientist who claims to have isolated the genes responsible for psychopathic behavior, Erin realizes it may be possible to reverse the condition, restoring souls to psychopaths. But to do so, she’ll not only have to operate outside the law, but violate her most cherished ethical principles.
As Erin becomes further involved with Raborn, she begins to suspect that he harbors dark secrets. Is he working for the good of society? Or is he intent on bringing humanity to its knees?
“THE CURE will keep you turning the pages all night long.”
–Douglas Preston, NEW YORK TIMES #1 bestselling author of IMPACT
“Richards is a tremendous new talent. THE CURE is an extraordinarily good novel that will keep you riveted . . . and thinking.”
–Stephen Coonts, NEW YORK TIMES bestselling author of PIRATE ALLEY
Douglas E. Richards is the NEW YORK TIMES and USA TODAY bestselling author of WIRED, its sequel, AMPED, and THE CURE. He has been widely praised for his ability to weave action, suspense, and science into riveting novels that straddle the thriller and science fiction genres. A former biotech executive, Richards earned a BS in microbiology from the Ohio State University, a master’s degree in genetic engineering from the University of Wisconsin (where he engineered mutant viruses now named after him), and an MBA from the University of Chicago.
To learn more about Douglas, please visit him on Facebook.
Interested in becoming a member of the International Thriller Writers? ITW offers Active and Associate memberships.
Latest posts by ITW (see all)
- November 13 – 19: “Can holidays like Thanksgiving be effectively used as the backdrop in thrillers?” - November 12, 2017
- November 6 – 11: “Is tone linked more to the author’s or the character’s attitude?” - November 5, 2017
- The November 2017 Edition of The Big Thrill is Here! - October 31, 2017